REFERENCES
- Kafarski, P.; Zon, J. Synthesis of α-aminophosphonic and α-aminophosphinic acids. In: V.P. Khukhar, H.R. Hudson (Eds.), Aminophosphonic and Aminophosphinic Acids: Chemistry and Biological Activity; Wiley: Chichester, 2000; pp. 33-74.
- Keglevich, G.; Balint, E. Molecules. 2012, 17, 12821-12835.
- Hudson, H.R.; Lee, R.J.; Matthews, R.W. Phosphorus Sulfur Silicon Relat. Elem. 2004, 179, 1691-1709.
- Green, D.StC.; Gruss, U.; Hägele, G.; Hudson, H.R.; Lindblom, L.; Pianka, M. Phosphorus, Sulfur Silicon Relat. Elem. 1996, 113, 179-207.
- Issleib, K.; Döpfer, K.P.; Balszuweit, A. Z. Naturforsch., 1981, 36B, 1392-1394.
- Issleib, K.; Döpfer, K.P.; Balszuweit, A. Phosphorus Sulfur. 1983, 14, 171-178.
- Khukhar, V.P.; Hudson, H.R. (Eds.). Aminophosphonic and Aminophosphinic Acids: Chemistry and Biological Activity, Wiley: Chichester, 2000.
- Quin, L.D. A Guide to Organophosphorus Chemistry, Wiley: New York, 2000.
- Dus, D.; Wojdat, E.; Radzikowski, C.; Mastalerz, P. Arch. Immunol. Ther. Ex. 1985, 33, 325-329.
- Lejczak, B.; Dus, D.; Kafarski, P. Anti Cancer Drug Design. 1990, 5, 351-358.
- Kalir, A.; Kalir, H.H. Biological activity of phosphonic and phosphinic acids. In: F.R. Hartley (Ed.), The Chemistry of Organophosphorus Compounds, Vol. 4; Wiley: Chichester, 1996, 767-780.
- Kafarski, P.; Lejczak, B. Curr. Med. Chem: Anti-Cancer Agents. 2001, 1, 301-312.
- Khayat, D.; Lokiec, F.; Bizarri, J.P.; Weil, M.; Meeus, L.; Sellami, M.; Rouesse, J.; Banzet, P.; Jacquillat, C. Cancer Res. 1987, 47, 6782-6785.
- Sweetman, S.C. (Ed.): Martindale: The Complete Drug Reference, 37th ed.; Pharmaceutical Press: London, 2011, p. A:795-3.
- De Rossi, A., Rossi, L., Laudisi, A., Sini, V. Toppo, L., Marchesi, F., et al. J. Exp. Clin. Cancer Res. 2006, 25, 461-468.
- Lavielle, G.; Hautefaye, P.; Schaeffer, C.; Boutin, J.A.; Cudennec, C.A.; Pierre, A. J. Med. Chem. 1991, 34, 1998-2003.
- Lelievre, E.; Guillaudeux, J.; Cardona, H.; Bourguignat, A.; Lokiec, F.; Solere, P.; Lucas, C.; Sauveur, C. Cancer Res. 1993, 53, 3536-3540.
- Fischel, J.L.; Berlion, M.; Formento, P.; Bizzari, J.P.; Milano, G. Eur. J. Cancer. 1993, 29A, 1890-1894.
- Adenis, A.; Pion, J.M.; Fumoleau, P.; Pouillart, P.; Marty, M.; Giroux, B.; Bonneterre, J. Cancer Chemother. Pharmacol. 1995, 35, 527-528.
- Song, B.; Yang, S.; Hong, Y.P.; Zhang, G.P.; Jin, L.H.; Hu, D.Y. J. Fluorine Chem. 2005, 126, 1419-1424.
- Jin, L.H.; Song, B.; Zhang, G.P.; Xu, R.Q.; Zhang, S.M.; Gao, X.W.; Hu, D.Y.; Yang, S. Bioorg. Med. Chem. Lett. 2006, 16, 1537-1543.
- Hahn, F.E. Naturwiss. 1980, 67, 307.
- β-Carbolines are well known to be biologically active and many exhibit antitumour activity (cf. Cao, R.; Peng, W.; Wang, Z.; Xu, A. Current Med. Chem. 2007, 14, 479-500, and cited references).
- Wang, Q.M.; Chen, Z.; Zeng, Q.; Huang, R.Q. Heteroatom. Chem. 1999, 10, 209-212.
- Wang, B.; Miao, Z.W.; Wang, J.; Chen, R.Y.; Zhang, X.D. Amino Acids, 2007, 35, 463-468.
- Bloemink, M.J.; Diederen, J.J. H.; Dorenbos, J.P.; Heetebrij, R.J.; Keppler, B.K.; Reedijk, J. Eur. J. Inorg. Chem. 1999, 1655-1657.
- Gluza, K.; Kafarski, P. Inhibitors of proteinases as potential anti-cancer agents. In: C. Rundfeldt (Ed.), Drug Development - A Case Study Based Insight into Modern Strategies; InTech, 7 December, 2011 . pp. 39-74.
- Mucha, A.; Kafarski, P.; Berlicki, L. J. Med. Chem. 2011, 54, 5955-5980.
- Naydenova, E.; Troev, K.; Topashka-Ancheva, M.; Hägele, G.; Ivanov, I.; Kril, A. Amino Acids. 2007, 33, 695-702 and cited references.
- Li, Q.; Lambrechts, M.J.; Zhang, Q.; Liu, S.; Ge, D.; Yin, R.; Xi, M.; You, Z. Drug Des. Dev. Ther. 2013, 7, 635-643.
- Data from the DTP website, http://dtp.nci.nih.gov/dtpstandard/cancerscreeningdata/index.jsp Accessed January 2014.
- Paull, K.D.; Shoemaker, R.H.; Hodes, L.; Monks, A.; Scudiero, D.A.; Rubinstein, L.; Plowman, J.; Boyd, M.R. J. Natl. Cancer Inst. 1989, 81, 1088-1092.
- NCI-60 DTP Human Tumor Cell Line Screen, http://dtp.nci.nih.gov/branches/btb/ivclsp.html Accessed January 2014.